Analysis, Network Mapping, and Accountability Record
Unredacted EU Advance Purchase Agreements · Pfizer 5.3.6 Post-Marketing Adverse Event Report · Comirnaty Occupational Safety Datasheet · EMA Correspondence with MEPs (Oct 2023) · Rothschild & Co Self-Published Investor Materials · Verified Press Reporting
The following are established beyond reasonable dispute by primary source documentation. No claim beyond the evidence is made.
Every connection shown here is established by primary sources. No inference beyond the documented evidence is asserted.
The central figure. She personally negotiated the €35bn Pfizer deal by private text message with CEO Bourla. Those texts were deleted or declared lost. The EU General Court found the explanation implausible.
Background: Born Brussels 1958. Attended the European School — the institution created for children of EU civil servants. Entered German politics 2003. Appointed to four successive cabinet posts by Merkel (2005–2019) — the only minister to serve continuously throughout all four Merkel governments. Domestic career damaged by Defence Ministry procurement scandals and doctoral plagiarism challenge. Rescued by Macron's 2019 European Council manoeuvre.
Current status: Under EPPO investigation for interference in public functions, destruction of SMS, corruption, and conflict of interest. No charges filed. Re-elected Commission President July 2024.
Personally negotiated with Von der Leyen by private text and phone. Twice declined invitations to testify before the European Parliament's COVID committee. Jointly received the Atlantic Council's Distinguished Leadership Award with Von der Leyen in November 2021 — calling her "dear Ursula" and saying he had "almost cried" by her words — while the Commission was under investigation for how the contracts were negotiated.
Formal signatory of both contracts — her signature legally bound all 27 Member States. Appointed by Von der Leyen. Before MEPs she insisted "the Commission president was not involved in any COVID vaccine contract negotiations" — directly contradicted by Von der Leyen's own admission to the New York Times that she negotiated by text.
Von der Leyen's kingmaker — proposed her at the deadlocked 2019 European Council and engineered her appointment. Her primary backer for a second term.
From 2008–2012 he worked at Rothschild & Cie Banque, rising to Managing Director in two years. His first major deal: Nestlé's $11.8bn acquisition of Pfizer's baby food division — his first documented professional relationship with Pfizer. The FT named him David de Rothschild's protégé; Rothschild described his presidential rise as "the planets aligning."
In 2021 Macron was among the most aggressive European leaders pushing vaccine access restrictions — France implemented a vaccine pass covering restaurants, transport, and public life.
Von der Leyen's long-term political patron across 14 years and four cabinet posts — and the EU leader who actively blocked the TRIPS IP waiver throughout 2021, protecting the monopolies guaranteed in the contracts her protégé had negotiated.
Von der Leyen was the only minister to serve continuously in all four Merkel governments. When her Defence Ministry career was damaged, Merkel kept her. When Macron proposed Von der Leyen at the 2019 European Council, she was described as "an option Merkel could not refuse — she came from Merkel's own country, her own party, and was a personal confidante."
| Person | Role | Key Action | Status |
|---|---|---|---|
| Ursula von der Leyen | EU Commission President | Negotiated Pfizer deal by private SMS; texts deleted/lost; husband appointed pharma exec Sep 2020 — undisclosed | EPPO Investigation |
| Albert Bourla | Pfizer CEO | Negotiated by SMS; refused to testify to Parliament twice; joint Atlantic Council award with VdL during investigation | No investigation |
| Stella Kyriakides | EU Health Commissioner | Formal signatory of both contracts; denied VdL involvement — contradicted by VdL's own NYT admission | No investigation |
| Emmanuel Macron | President of France | Installed VdL as Commission President; pushed vaccine access restrictions; former Rothschild protégé; first deal was for Pfizer | No investigation |
| Angela Merkel | Chancellor 2005–21 | Blocked TRIPS IP waiver protecting pharma monopolies; VdL's patron 14 years, 4 cabinet appointments | No investigation |
| Nanette Cocero | Pfizer Vaccines President | Signed Pfizer APA binding 27 Member States | No investigation |
| Stéphane Bancel | Moderna CEO | Signed Moderna APA binding 27 Member States | No investigation |
The individuals above did not emerge independently. They form an interlocking network of relationships — educational, professional, and institutional — that shaped both who made the decisions and why those decisions followed the pattern they did. Every element below is individually documented and uncontested.
In April 2021 — during the peak of EU vaccine procurement — Rothschild & Co Wealth Management published on their own website an investor interview with Pfizer's Investor Relations Officer Bryan Dunn, conducted by their own equity analysts.
This is not a journalist observing the connection from outside. It is Rothschild & Co documenting their own relationship with Pfizer, on their own platform, as routine wealth management content. The openness signals confidence, not concealment — the behaviour of a network that does not consider its position problematic because the system that would hold it problematic is the same system it operates within.
Von der Leyen received the Distinguished International Leadership Award. Bourla received the Distinguished Business Leadership Award. Von der Leyen personally presented Bourla's award, calling him "dear Albert," crediting him with saving "millions of lives," saying "we trusted each other." Bourla said he was "speechless" and had "almost cried." The Commission had by then signed three Pfizer contracts worth approximately €35bn. The EPPO investigation was ongoing. The text messages had not yet been demanded by the New York Times.
Axis 1 — Rothschild/Macron: Rothschild & Cie → Macron (protégé, Pfizer deal 2012) → Macron installs Von der Leyen (2019) → Von der Leyen negotiates €35bn Pfizer contract (2021). Simultaneously: Rothschild & Co publishes investor interview with Pfizer (April 2021).
Axis 2 — Merkel: Merkel builds Von der Leyen across four cabinet appointments (2005–2019) → Merkel's blessing enables Von der Leyen's EU elevation → Merkel blocks TRIPS waiver protecting Pfizer IP (2021).
Von der Leyen is the hinge point. Both axes converge on the same corporate beneficiary: Pfizer — €35bn in contracts negotiated off the record, liability transferred to citizens, IP protected by a G7 veto, evidence subsequently destroyed.
Von der Leyen's husband Heiko became Medical Director of Orgenesis — an American biopharmaceutical company active in COVID-19 vaccine development — in September 2020, the same month EU procurement strategy was being finalised. Orgenesis subsequently received EU funding. Von der Leyen did not publicly disclose this in relation to her procurement role.
The European Commission concluded Advance Purchase Agreements on behalf of all 27 participating Member States under Emergency Support Instrument (EU) 2020/521. The formal signatory was Commissioner Kyriakides. The actual negotiator, by Von der Leyen's own admission to the New York Times, was Von der Leyen herself.
Under Article 7 of the framework agreement, participating Member States agreed not to negotiate separately with the same manufacturers — locking all 27 into whatever terms the Commission had agreed.
| Volume Tier | Price Per Dose (excl. VAT) |
|---|---|
| Doses 1–100 million | €17.50 |
| Doses 101–200 million | €13.50 |
| Average across 200M doses | €15.50 |
| Additional order (≤3 months post-authorisation) | €15.50 |
| Additional order (thereafter) | €17.50 |
Advance Payment: €700 million — payable within 20 business days of signing, before any doses were delivered, before authorisation was received. Paid to Pfizer Inc. EUR Account, Citibank Dublin, Ireland.
Both contracts transferred all liability for adverse events from the manufacturers to the Member States and ultimately to citizens. The companies were indemnified for any liability arising from the use and deployment of the vaccines. This provision was redacted from the publicly released versions.
Both contracts grant Pfizer and Moderna sole ownership of all IP generated during development — IP substantially funded by EU taxpayers through advance payments. This connects directly to Merkel's blocking of the TRIPS waiver, which would have permitted other manufacturers to produce vaccines using that IP without licensing restrictions.
Within 90 days of rollout, Pfizer had identified 1,291 adverse event categories of special interest across 42,086 case reports. This was submitted to the FDA, which sought to withhold it from public release for 75 years. Federal court orders required earlier disclosure. Member States were contractually indemnifying Pfizer against losses from these events while citizens were told the vaccines were safe without qualification.
The Comirnaty occupational safety datasheet classifies the active mRNA substance at OEB5 — the highest hazard band for occupational exposure. Toxicological properties are described as "not thoroughly investigated." The datasheet requires respiratory protection, full body protective clothing, and eye protection when handling the substance.
This document was not proactively distributed to healthcare workers administering it, as required by workplace safety law. Download links from official sites were redacted. BioNTech appeared unable to locate the document promptly when requested by the German Federal Ministry of Health.
"COVID-19 vaccines have not been authorised for preventing transmission from one person to another. The authorised indication is protection of the vaccinated individual only." European Medicines Agency — Letter to MEP Marcel de Graaff et al., 18 October 2023 (EMA/451828/2023)
Transmission prevention was the stated justification for vaccine passports and access restrictions that functionally compelled vaccination across Europe without formal mandate. The EMA's written confirmation means those restrictions lacked the scientific basis on which they were publicly justified.
Formal vaccine mandates were rejected democratically in Germany — the Bundestag voted against compulsory vaccination on 7 April 2022 (primary proposal defeated 378–296). Near-equivalent compulsion was implemented by executive action through the 2G/3G access restriction system — bypassing the same parliamentary scrutiny that had defeated formal mandates.
| Rule | Who Qualified | Where Applied |
|---|---|---|
| 3G | Vaccinated, recovered, or tested | Workplaces and public transport |
| 2G | Vaccinated or recovered only — no test alternative | Bars, restaurants, cinemas, museums, events |
| 2G+ | Vaccinated/recovered + PCR test | High-incidence states and settings |
Citizens were coerced into accepting a product whose long-term effects their governments had acknowledged in writing were unknown, on the basis of a transmission-prevention claim the authorising regulator had not made, under contracts that transferred all liability to those same citizens, negotiated by officials with undisclosed conflicts of interest, using communications that were subsequently destroyed.
A parallel accountability problem exists regarding Merkel's past in the German Democratic Republic — following the same structural pattern as Von der Leyen's deleted text messages: the person with most to lose controls whether the evidence is seen.
Hans-Georg Maaßen — former President of the Verfassungsschutz (Germany's domestic intelligence service), dismissed by Merkel — stated publicly:
"The release of Ms. Merkel's Stasi file is necessary in the interest of democracy, because citizens have a right to know whether they have been governed by a former operative of the Stasi and/or the KGB. If she had merely been a low-level employee of an administrative agency, her file would have had to be released long ago." Hans-Georg Maaßen, January 2025 — Former President, Bundesverfassungsschutz
Maaßen's statement carries particular weight: he held the highest domestic intelligence position in Germany, was dismissed by Merkel, and his phrasing implies the file should have been released automatically if it were merely an administrative victim file — suggesting he has reason to believe it is not.
Marcel Luthe brought a lawsuit before the Berlin Administrative Court to force release of Merkel's Stasi file. On 13 March 2026, the First Chamber found that Luthe had "no legal claim to the release" under the Stasi Records Act. He was ordered to pay €20,000 in costs. The file remains sealed.
The mechanism: the Federal Archive classifies Merkel's possible file as a non-perpetrator file — triggering personal data protection provisions. Without Merkel's own consent, the file cannot be released. Merkel refuses to consent.
The classification as victim vs. perpetrator file is itself the question at issue. Whether Merkel was an informant or merely surveilled cannot be determined without seeing the file. But the file cannot be seen unless the question is already resolved in her favour. The court accepted the circular logic. The case had also been delayed for over a year before being heard.
Not proven: That Merkel was Stasi IM "Erika" or any registered informant. Historian Hubertus Knabe concluded: "There is no evidence whatsoever for the claim that Chancellor Merkel worked for the Stasi under the codename 'Erika.' If a corresponding IM file had existed, traces of it should still remain — and that is not the case based on current knowledge."
Established: Merkel enjoyed privileges in the DDR inconsistent with her official status. Her professional environment was heavily infiltrated. Her first political patron was a confirmed Stasi informant. Her file exists. She refuses to release it. The court accepted her refusal.
Von der Leyen: Communications revealing who instructed the Pfizer deal were destroyed. The person whose conduct is in question controlled the evidence.
Merkel: Documents revealing DDR intelligence relationships are sealed. The person whose conduct is in question controls consent to release.
In both cases, the institutional system that would compel disclosure is the same system that accepted the explanation for why disclosure cannot happen.
Earlier research sessions contained a citation error: material about the Merkel/Von der Leyen relationship was incorrectly attributed to the Rothschild & Co website. That website contains only their investor interview with Pfizer. The Merkel/VdL material is sourced to Foreign Policy and France 24, corrected below.
| Claim | Correct Source | URL / Reference |
|---|---|---|
| Merkel placed trust in VdL as unproven politician | Foreign Policy, 30 Apr 2021 | foreignpolicy.com — "The Aristocratic Ineptitude..." |
| VdL "loyal confidante" of Merkel; likely successor | France 24, 1 Dec 2019 | france24.com — "Merkel loyalist, favoured by Macron" |
| VdL only minister in all four Merkel cabinets | France 24 (2019); Wikipedia | en.wikipedia.org/wiki/Ursula_von_der_Leyen |
| 2018 reappointment as sign of Merkel confidence | CDU official biography | kas.de — CDU Geschichte |
| Macron as Rothschild protégé; FT description | Financial Times (2018); Factually.co | factually.co/fact-checks/politics/macron-rothschild-connections |
| Macron's Pfizer deal at Rothschild (Nestlé APA) | Money.com; Wikipedia | money.com/emmanuel-macron-french-president-wealth-net-worth-rich |
| Rothschild & Co investor interview with Pfizer [self-published] | Rothschild & Co own website, April 2021 | rothschildandco.com — "Investment Views: An interview with Pfizer" |
| Merkel blocking TRIPS waiver | Human Rights Watch, 14 Jun 2021 | hrw.org — "Merkel should steer EU COVID-19 IP waiver" |
| Atlantic Council ceremony — VdL and Bourla | WorldNews, 17 Nov 2021 | article.wn.com — Atlantic Council ceremony |
| EMA: vaccines not authorised for transmission | EMA letter to MEP de Graaff, 18 Oct 2023 | Project file: 2023_10_18_Letter_to_MEP_Marcel_de_Graaff...pdf |
| Pfizer 1,291 adverse event categories in 90 days | Pfizer 5.3.6 post-marketing report | Project file: 5_3_6postmarketingexperience.pdf |
| Maaßen statement on Merkel Stasi file | Facebook post, Jan 2025; Journalistenwatch; Philosophia Perennis | Facebook (verified) |
| Berlin Administrative Court ruling, Mar 2026 | Berliner Zeitung, 13 Mar 2026; elizaonsteroids.org | berliner-zeitung.de |
| EPPO investigation of VdL | EPPO public statements; mainstream press | Multiple outlets 2022–2024; eppo.europa.eu |
The following are established beyond reasonable dispute by the primary source record:
This document is based on primary source documentation. All factual claims about individuals are drawn from verified sources cited inline. The EPPO investigation is ongoing; no criminal findings have been made. Source attribution has been reviewed and corrected in this version. No inference beyond the documented evidence is asserted.